County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other, Procedure, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this cluster randomized trial is to evaluate the effectiveness of the RISIMA model based on an integrated county healthcare consortium implemented by multi-level family health teams (FHTs)on patients with diabetes and/or hypertension, including CVD risk assessment, treatment, and management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 70
Healthy Volunteers: f
View:

• Aged between 40 and 70 years old;

• Patients with hypertension or diabetes;

• Permanent residents of the county where the research is conducted;

• Already signed up with the family doctor team in the township where the research is located.

Locations
Other Locations
China
Luzhai County People's hospital
RECRUITING
Liuzhou
Luzhai County Traditional Medicine hospital
RECRUITING
Liuzhou
Shaxian County General Hospital
RECRUITING
Sanming
Contact Information
Primary
Jin Prof. Xu, PhD
xujin@hsc.pku.edu.cn
0086-82805701
Time Frame
Start Date: 2024-05-20
Estimated Completion Date: 2025-12-20
Participants
Target number of participants: 2560
Treatments
No_intervention: Control
During the study, control participant will be provided with existing essential public health service including quarterly follow-ups and annual physical examination, and be advised to see their usual provider for care, as appropriate.
Experimental: Intervention
Intervention group will receive the risk-stratified integrated CVD management (RISIMA) model consisting of 5 core elements provided as a package: (1) Team-based care; (2) Risk-stratified care pathway; (3) Strengthened health education; (4) Financial incentives for integration of care; (5) Supporting health information system.
Related Therapeutic Areas
Sponsors
Leads: Peking University

This content was sourced from clinicaltrials.gov